Advisory Board May 8, 2024
Currently, the vast majority of Alzheimer’s cases don’t have a clearly identified cause, but a new study published in Nature Medicine suggests that having two variants of the APOE4 gene could be the cause behind specific cases of the disease.
Top drivers of change in the neurodegenerative disease market
Study details
For the study, researchers analyzed pathological data from 3,297 brain donors and biomarkers and clinical data from 10,039 people, including over 500 people with two copies of APOE4, a gene variant that has long been known to increase a person’s risk of developing Alzheimer’s.
The researchers found that nearly every patient with two copies of APOE4 developed the biological pathology of Alzheimer’s. By age 55, more than 95% of...